Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: A 20-year multicentre experience

Gut

Volumn 59, Issue 3, 2010, Pages 387-396

  Mirici Cappa, Federica ^a   Gramenzi, Annagiulia ^a   Santi, Valentina ^a   Zambruni, Andrea ^a   Micoli, Antonio Di ^a   Frigerio, Marta ^a   Maraldi, Francesca ^a   Di Nolfo, Maria Anna ^b   Del Poggio, Paolo ^c   Benvegnù, Luisa ^d   Rapaccini, Gianludovico ^e   Farinati, Fabio ^d   Zoli, Marco ^a   Borzio, Franco ^f   Giannini, Edoardo Giovanni ^g   Caturelli, Eugenio ^h   Bernardi, Mauro ^a   Trevisani, Franco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b BOLOGNINI HOSPITAL   (Italy)

^c TREVIGLIO HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f FATEBENEFRATELLI HOSPITAL   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h BELCOLLE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMOEMBOLIZATION; COMORBIDITY; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; LAPAROSCOPY; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL;

AGE FACTORS; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; EPIDEMIOLOGIC METHODS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME;

EID: 77749317233     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.194217     Document Type: Article

References (29)

1. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:5-16.
2. El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 2001;33:62-5.
3. Michielsen PP, Sven MF, Van Dongen JL. Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol 2005;3:27. doi: 10.1186/1477-7819-3-27.
4. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Clini Gastroenterol 2005;19:3-23.
5. Liaw YF, Tai DI, Chu CM, et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology 1986;90:263-7.
6. Cammà C, Giunta M, Andreone P, et al. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: An evidence-based approach. J Hepatol 2001;34:593-602.
7. Bugianesi E. Non-alcoholic steato-hepatitis and cancer. Clin Liver Dis 2007;11:191-207.
8. Nomura F, Ohnishi K, Honda M, et al. Clinical features of hepatocellular carcinoma in the elderly. Br J Cancer 1994;70:690- 3.
9. Collier JD, Curless R, Bassedine MF, et al. Clinical features and prognosis of hepatocellular carcinoma in Britain in relation to age. Age Ageing 1994;23:22-7.
10. Poon RT, Fan ST, Lo CM, et al. Hepatocellular carcinoma in the elderly: results of surgical and non-surgical management. Am J Gastroenterol 1999;94:2460-6.
11. Dohem K, Shirahama M, Shigematsu H, et al. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2004;19:859-65.
12. Tsukioka G, Kakikazi S, Sohara N, et al. Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patients survival. World J Gastroenterol 2006;12:48-53.
13. Pignata S, Gallo C, Daniele B, et al. Characteristic at presentation and outcome of hepatocellular carcinoma(HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). Crit Rev Oncol Hematol 2006;59:243-9.
14. El-Serag HB, Siegel AB, Davila JA, et al. Treatment and outcomes of treating hepatocellular carcinoma among medicare recipients in the United States: a population-based study. J Hepatol 2006;44:158-66.
15. Capocaccia R, Sant M, Berrino F, et al. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol 2007;102:1661-70.
16. Pugh NH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
17. Commissione "Epatocarcinoma" dell'Associazione Italiana per lo Studio del Fegato. Epatocarcinoma: Linee Guida per la Diagnosi e la Terapia. Bologna: Tipografia Moderna, 1998: 235-86.
18. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the Study of the liver. J Hepatol 2001;35:421-30.
19. Trevisani F, Caraceni P, Bernardi M, et al. Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer 1993;72:1557-63.
20. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000;31:840-5.
21. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
22. Trevisani F, De Notariis S, Rapaccini G, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002;97:734-44.
23. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non randomized control group. Stat Med 1998;17:2265-81.
24. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-76.
25. Rocca LG. Management of patients with hepatitis C in a community setting: diagnosis, discussions and decisions to treat. Ann Fam Med 2004;2:116-24.
26. MacMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of carrier state. J Infect Dis 1985;151:599-602.
27. Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004;127:72-8.
28. Trevisani F, Cantarini MC, Wands JR, et al. Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis 2008;29:1229-305.
29. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. Hepatology 2008;48:20-37.